Free Trial

MoonLake Immunotherapeutics (MLTX) Earnings Date, Estimates & Call Transcripts

MoonLake Immunotherapeutics logo
$17.01 -0.55 (-3.13%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$16.96 -0.05 (-0.29%)
As of 05/5/2026 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MoonLake Immunotherapeutics Earnings Summary

MoonLake Immunotherapeutics released Q4 2025 earnings on February 25, 2026, reporting an EPS of -$0.92, which met the consensus estimate of -$0.92. With a trailing EPS of -$3.52, MoonLake Immunotherapeutics' earnings are expected to decrease next year, from ($3.42) to ($3.62) per share.

Upcoming
Earnings Date
May. 11Before Market OpensEstimated
Consensus EPS
(Feb. 25)
-$0.92
Actual EPS
(Feb. 25)
-$0.92

Q4 2025 Earnings Resources

MLTX Upcoming Earnings

MoonLake Immunotherapeutics' Q1 2026 earnings is estimated for Monday, May 11, 2026, based on past reporting schedules, with a conference call scheduled on Thursday, May 14, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get MoonLake Immunotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MoonLake Immunotherapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MLTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MoonLake Immunotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.86-$0.63-$0.75
Q2 20262-$0.87-$0.77-$0.82
Q3 20262-$0.88-$0.75-$0.82
Q4 20262-$0.91-$0.72-$0.82
FY 2026 8 -$3.52 -$2.87 -$3.20
Q1 20271-$0.70-$0.70-$0.70
Q2 20271-$0.82-$0.82-$0.82
Q3 20271-$0.91-$0.91-$0.91
Q4 20271-$0.67-$0.67-$0.67

MoonLake Immunotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/11/2026
(Estimated)
--------
2/25/2026Q4 2025-$0.92-$0.92--$0.92--
11/5/2025Q3 2025-$0.89-$1.10 -$0.21-$1.10--
8/5/2025Q2 2025-$0.73-$0.87 -$0.14-$0.87--
5/12/2025Q1 2025-$0.76-$0.63+$0.13-$0.63--
2/26/2025Q4 2024-$0.63-$0.72 -$0.09-$0.72--
11/7/2024Q3 2024-$0.44-$0.56 -$0.12-$0.56--
8/7/2024Q2 2024-$0.28-$0.39 -$0.11-$0.39--
5/12/2024Q1 2024-$0.19-$0.22 -$0.03-$0.22--

Data powered by Fiscal.ai.

MoonLake Immunotherapeutics Earnings - Frequently Asked Questions

MoonLake Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 11th, 2026 based off last year's report dates. Learn more on MLTX's earnings history.

In the previous quarter, MoonLake Immunotherapeutics (NASDAQ:MLTX) reported ($0.92) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.92). Learn more on analysts' earnings estimate vs. MLTX's actual earnings.

MoonLake Immunotherapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

MoonLake Immunotherapeutics (NASDAQ:MLTX) has a recorded net income of -$227.32 million. MLTX has generated -$3.52 earnings per share over the last four quarters.

MoonLake Immunotherapeutics' earnings are expected to decrease from ($3.42) per share to ($3.62) per share in the next year.


This page (NASDAQ:MLTX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners